Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study
This study demonstrates the safety of ultra-hypofractionated radiation therapy in terms of toxicity in patients with breast cancer. The findings for side effects, cosmesis, quality of life, and survival outcomes are consistent with those observed in moderately hypofractionated radiation therapy regimens, suggesting its use as a viable treatment option in this demographic.
Authors
- Rossana Veronica Mendoza López (ORCID: https://orcid.org/0000-0001-7993-767X)
- Lucas Coelho Casimiro
- Gabriele Pinto
- Vinícius de Carvalho Gico (ORCID: https://orcid.org/0000-0003-0520-4320)
- Marcel Fang (ORCID: https://orcid.org/0000-0001-8059-6913)
- Elson Santos Neto (ORCID: https://orcid.org/0000-0002-2394-5504)
- Gustavo Nader Marta (ORCID: https://orcid.org/0000-0002-3298-3684)
- Bruno Takatsu (ORCID: https://orcid.org/0009-0007-0929-8885)
Institutions
- Universidade de São Paulo (BR)
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- AC Camargo Hospital (BR)
- Instituto do Câncer do Estado de São Paulo (BR)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Hospital Sírio-Libanês (BR)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1200/go-24-00277
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00